(Q40096619)

17 September 2017

1 reference

title

Combined alpha- and beta-receptor inhibition in the treatment of hypertension (English)

1 reference

17 September 2017

Prichard BN

1

1 reference

17 September 2017

publication date

1 January 1984

1 reference

17 September 2017

1 reference

17 September 2017

volume

28 Suppl 2

1 reference

17 September 2017

page(s)

51-68

1 reference

Emergency treatment of severe hypertension with intravenous labetalol

17 September 2017

cites work

1 reference

12 December 2020

Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared

1 reference

12 December 2020

Rate of onset of hypotensive effect of oral labetalol

1 reference

12 December 2020

1 reference

12 December 2020

Scalp tingling in patients on labetalol

1 reference

12 December 2020

Sympathetic nervous activity and the pressor effect of noradrenaline under chronic?-?-adrenoceptor blockade with labetalol in hypertension

1 reference

12 December 2020

The evaluation of labetalol in the treatment of hypertension complicating pregnancy

1 reference

12 December 2020

Types and Functions of Peripheral α-Adrenoceptors

1 reference

12 December 2020

Intravenous labetalol in hypertensive patients given by fast and slow injection

1 reference

12 December 2020

Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension

1 reference

12 December 2020

Controlled comparison of labetalol and propranolol in the management of severe hypertension

1 reference

12 December 2020

Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension

1 reference

12 December 2020

Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.

1 reference

12 December 2020

Rapid onset of action of oral labetalol in severe hypertension

1 reference

12 December 2020

Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow.

1 reference

12 December 2020

Hypertensive response to labetalol in phaeochromocytoma.

1 reference

12 December 2020

Elimination kinetics of labetalol in severe renal failure

1 reference

12 December 2020

Effect of labetalol in hypertension during exercise and postural changes

1 reference

12 December 2020

Labetalol in severe tetanus

1 reference

12 December 2020

Clinical pharmacology of labetalol

1 reference

12 December 2020

Use of labetalol in the treatment of severe hypertension during pregnancy

1 reference

12 December 2020

Hypertensive response to labetalol in phaeochromocytoma

1 reference

12 December 2020

Bullous lichen planus caused by labetalol

1 reference

12 December 2020

Poor hypotensive response and tachyphylaxis following intravenous labetalol

1 reference

12 December 2020

Central and Peripheral α-Adrenoceptors

1 reference

12 December 2020

Labetalol in long-term treatment of hypertension

1 reference

12 December 2020

A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension

1 reference

12 December 2020

Bronchial and cardiac beta-adrenoceptor blockade-a comparison of atenolol, acebutolol and labetalol

1 reference

12 December 2020

Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension

1 reference

12 December 2020

Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma

1 reference

12 December 2020

Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion

1 reference

12 December 2020

Labetalol in severe and resistant hypertension

1 reference

12 December 2020

A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group

1 reference

12 December 2020

Effects of Labetalol on Plasma Renin, Aldosterone, and Catecholamines in Hypertensive Patients

1 reference

12 December 2020

Haemodynamic effects of long-term oral labetalol

1 reference

12 December 2020

The use of labetalol in Japan: results of multicentre clinical trials

1 reference

12 December 2020

Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study

1 reference

12 December 2020

A comparative study of methyldopa and labetalol in the treatment of hypertension

1 reference

12 December 2020

Labetalol-induced toxic myopathy

1 reference

12 December 2020

Labetalol in general practice: a review

1 reference

12 December 2020

Pharmacology of combined alpha-beta-blockade. I

1 reference

12 December 2020

Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension

1 reference

12 December 2020

Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma

1 reference

12 December 2020

SLE syndrome, probably induced by labetalol

1 reference

12 December 2020

Labetalol in tetanus. The treatment of sympathetic nervous system overactivity.

1 reference

12 December 2020

Alpha-adrenoceptor blockade by labetalol during long-term dosing

1 reference

12 December 2020

Treatment of hypertension following endotracheal intubation. A study comparing the efficacy of labetalol, practolol and placebo

1 reference

12 December 2020

Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol

1 reference

12 December 2020

Labetalol in the treatment of hypertension in patients with normal and impaired renal function

1 reference

12 December 2020

Use of labetalol in hypertensive patients during discontinuation of clonidine therapy

1 reference

12 December 2020

Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine

1 reference

12 December 2020

Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension

1 reference

12 December 2020

Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma

1 reference

12 December 2020

Intravenous labetalol in the treatment of severe hypertension

1 reference

12 December 2020

Side-effects with long-term labetalol: an open study of 251 patients in a single centre

1 reference

12 December 2020

Review of long-term treatment with labetalol

1 reference

12 December 2020

Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients

1 reference

12 December 2020

Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings

1 reference

12 December 2020

Labetalol and bendrofluazide: comparison of their antihypertensive effects

1 reference

12 December 2020

Labetalol in resistant hypertension

1 reference

12 December 2020

Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.

1 reference

12 December 2020

Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects

1 reference

12 December 2020

Alpha and beta adrenergic blockade in hypertension.

1 reference

12 December 2020

Long-term treatment of hypertension with labetalol

1 reference

12 December 2020

Failure of labetalol to prevent hypertension due to clonidine withdrawal

1 reference

12 December 2020

Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol

1 reference

12 December 2020

Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent

1 reference

12 December 2020

A multicentre open trial of labetalol in New Zealand

1 reference

12 December 2020

Which beta-blocker in pregnancy-induced hypertension?

1 reference

12 December 2020

Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension

1 reference

12 December 2020

The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels

1 reference

12 December 2020

Rapid reduction of blood pressure with acute oral labetalol

1 reference

12 December 2020

Are the Pre- and Postsynaptic α-Adrenoceptors in Human Vascular Smooth Muscle Atypical?

1 reference

12 December 2020

Experience with labetalol in hypertension.

1 reference

12 December 2020

Comparison of labetalol and clonidine in hypertension

1 reference

12 December 2020

Labetalol and renal function

1 reference

12 December 2020

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Minoxidil and labetalol: very effective antihypertensive combination

1 reference

12 December 2020

A long-term study of labetalol in general practice

1 reference

12 December 2020

Double-blind trial of labetalol

1 reference

12 December 2020

Alpha- and beta-blockade in angina pectoris.

1 reference

12 December 2020

Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period.

1 reference

12 December 2020

Use of labetalol during halothane anaesthesia

1 reference

12 December 2020

Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment

1 reference

12 December 2020

Labetalol in the treatment of a patient with phaechromocytoma: a case report

1 reference

12 December 2020

The use of labetalol in anaesthesia

1 reference

12 December 2020

Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.

1 reference

12 December 2020

Labetalol in the treatment of patients with hypertension and renal function impairment

1 reference

12 December 2020

Intravenous labetalol in severe hypertension

1 reference

12 December 2020

A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension

1 reference

12 December 2020

The Effect of α-Adrenoreceptor Stimulation on the Airways of Normal and Asthmatic Man

1 reference

12 December 2020

Labetalol in the Preoperative Management of Phaeochromocytoma

1 reference

12 December 2020

Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension

1 reference

12 December 2020

Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol

1 reference

12 December 2020

Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study

1 reference

12 December 2020

Labetalol in Essential Hypertension

1 reference

12 December 2020

Effects of labetalol and methyldopa on renal function.

1 reference

12 December 2020

Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison

1 reference

12 December 2020

[Double-blind study against placebo of the efficacy and tolerance of labetalol 400 mg/day in moderate arterial essential hypertension in the adult]

1 reference

12 December 2020

Labetalol and pindolol in the treatment of hypertension: a comparative study

1 reference

12 December 2020

Treatment of severe hypertension with intravenous labetalol

1 reference

12 December 2020

A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension

1 reference

12 December 2020

Alpha-adrenoceptor blocking drugs in asthma

1 reference

12 December 2020

Cardiovascular effects of labetalol during halothane anaesthesia

1 reference

12 December 2020

The effects of labetalol and oxprenolol on blood lipids

1 reference

12 December 2020

Anti-hypertensive action, time of onset and effects on carbohydrate metabolism of labetalol

1 reference

12 December 2020

Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension

1 reference

12 December 2020

A method for monitoring drug effects on male sexual response: the effect of single dose labetalol

1 reference

12 December 2020

Labetalol and alprenolol. A comparative investigation of antihypertensive effect

1 reference

12 December 2020

A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension

1 reference

12 December 2020

Labetalol ('trandate') in hypertension: a multicentre study in general practice

1 reference

12 December 2020

Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension

1 reference

12 December 2020

Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension

1 reference

12 December 2020

Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension

1 reference

12 December 2020

A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease

1 reference

12 December 2020

Left ventricular failure with labetalol

1 reference

12 December 2020

Prejunctional modulation of noradrenaline release by alpha 2-adrenoceptors: physiological and pharmacological implications in the cardiovascular system

1 reference

12 December 2020

Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.

1 reference

12 December 2020

The effect of labetalol and propranolol on the pressor response to sexual arousal in women

1 reference

12 December 2020

Effects of Labetalol in Hypertensive Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Treatment of severe hypertension by repeated bolus injections of labetalol

1 reference

12 December 2020

Antinuclear Antibodies and Cardiovascular Drugs

1 reference

12 December 2020

Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension

1 reference

12 December 2020

Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo

1 reference

12 December 2020

10.2165/00003495-198400282-00005

Identifiers

DOI

0 references

1 reference